Viewing Study NCT06455202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-06-14 @ 7:12 PM
Study NCT ID: NCT06455202
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Sponsor: Celldex Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Spontaneous Urticaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CDX-0159 View
None barzolvolimab View
None chronic spontaneous urticaria View
None CSU View
None urticaria activity score View
None itch severity score View
None hives severity score View